Tumour metabolism in chemoprevention

Bookmark and Share
Published: 4 Aug 2016
Views: 1876
Dr Farhat Din – The University of Edinburgh, Edinburgh, UK

Dr Din speaks with ecancertv at the 2016 BACR and ECMC Joint Meeting about her research into the metabolic processes of aspirin in cancer cells

Using organoid models, she reports on the mechanisms by which aspirin inhibits mTOR signalling and protein regulation. 

Dr Din describes the additional impacts of diet, exercise and genetic susceptibility on tumour metabolism, and the population-level outcomes that wider adoption of chemoprevention could contribute towards.